ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1

Historical Institutional Holders from Q4 2015 to Q4 2021

All holders as of December 31, 2021
Q4 2021
Type / Class
Debt / NOTE 1.000%11/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2021 Q4 $0 $0 -$49.9M 0
2021 Q3 $49.8M $49.9M +$367K $1.00 18
2021 Q2 $49.5M $49.8M -$245M $1.00 22
2021 Q1 $292M $299M +$81.1M $1.02 40
2020 Q4 $214M $235M +$9.74M $1.08 40
2020 Q3 $210M $220M +$1.74M $1.03 42
2020 Q2 $208M $231M +$884K $1.10 47
2020 Q1 $207M $211M +$12.8M $1.01 48
2019 Q4 $194M $223M -$464M $1.14 51
2019 Q3 $603M $689M +$48.6M $1.14 58
2019 Q2 $560M $663M -$31.6M $1.19 58
2019 Q1 $569M $769M +$30.8M $1.35 58
2018 Q4 $552M $592M +$18.4M $1.07 49
2018 Q3 $516M $544M -$7.1M $1.05 44
2018 Q2 $524M $514M -$32M $0.98 46
2018 Q1 $555M $551M -$25.2M $0.99 53
2017 Q4 $581M $615M -$10.9M $1.06 50
2017 Q3 $592M $627M +$26.8M $1.06 42
2017 Q2 $566M $602M -$21.1M $1.06 44
2017 Q1 $587M $566M +$8.32M $0.96 44
2016 Q4 $577M $588M +$210M $1.02 44
2016 Q3 $371M $347M -$59.4M $0.93 40
2016 Q2 $459M $325M -$5.57M $0.71 47
2016 Q1 $461M $422M -$130K $0.91 40
2015 Q4 $443M $493M +$450M $1.13 41